Executive Management Team
Philip Libman, CEO
-
Over 40 years of managerial experience
-
Serial Entrepreneur in the last 15 years, medical devices and healthcare IT
-
Former Gartner Regional VP, covering Healthcare
Dr. Roger Mason, Founder, and CMO
-
Device Inventor; Yale MD
-
Fellowship with Dr. Michael DeBakey
-
Board-certified General & Vascular Surgeon for over 40 years
David Grey, Corporate Strategy Director
-
Senior Partner, Pharmes Innovations Limited
-
Global manager with over 47 years of experience in creating and managing multinational medical device companies in Europe, Asia and North America
-
Joined Access for Life in January 2016
Daniel Nadis, Chairman
-
40+ years of expertise in creating and managing multinational medical device organizations in the EU, Asia, and North America
-
Held senior positions with GE, Citibank, ThermoFisher, Toshiba, and Lumenis
-
Joined Access for Life in July 2018
Ken Green, CFO
-
President, Financial Consulting Firm; Big 4 Accounting Firm trained
-
Led the R&D Accounting & Finance Team, $2B biotech company
-
25 years experience
Scientific Advisory Team
Dr. Kirk Campbell
-
The Irene and Dr. Arthur M. Fishberg Professor of Medicine at the Icahn School of Medicine at Mount Sinai and Vice Chair of the Department of Medicine for Diversity, Equity, and Inclusion
-
Nephrologist, President-Elect of the National Kidney Foundation, National Board of Directors
-
Yale-trained MD
Dr. Igor Rabin
-
Head of the Vascular Surgery Dept., Yitzhak Shamir (Assaf Harofeh) Medical Center, Israel
-
Published researcher in vascular surgery
-
30 years experience
Mr. Jeremy Crane
- Consultant Transplant & Vascular Surgeon Imperial College Healthcare NHS Trust
- Honorary Senior Lecturer and the Lead for Education and Training in transplant and vascular access surgery
- Council member of VASBI (Vascular Access Society of Great Britain and Ireland).
- 22 years experience